Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p63 expression profile in normal and malignant prostate epithelial cells.

Leland D Davis1, Wei Zhang, Axel Merseburger

  • 1Center for Prostate Disease Research (CPDR), Department of Surgery, Uniformed Services University of the Health Sciences, 1530 East Jefferson Street, Rockville, MD 20852, USA.

Anticancer Research
|January 30, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Update of S3 guideline on metastatic prostate cancer-guideline recommendations and expert consensus].

Urologie (Heidelberg, Germany)·2026
Same author

Prostate-specific Antigen Response as a Prognostic Factor for Overall Survival in Patients with Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors: A Systematic Review and Meta-analysis.

European urology focus·2025
Same author

Enzalutamide versus abiraterone acetate in the development of new-onset or worsening type 2 diabetes mellitus in patients with metastatic castration-resistant prostate cancer: EVADE study.

World journal of urology·2024
Same author

Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression.

NPJ precision oncology·2024
Same author

Ohpikihâwasowin (grounding and guiding on the path to be a healthy parent): virtual adaptation of an Elders mentoring program to support maternal and child wellbeing during the COVID-19 pandemic.

BMC health services research·2024
Same author

A selective CutMix approach improves generalizability of deep learning-based grading and risk assessment of prostate cancer.

Journal of pathology informatics·2024

p63 protein is found in basal cells of the prostate, acting as a reliable marker for these cells. Its presence in cell cultures helps in identifying prostate cancer types.

Area of Science:

  • Oncology
  • Cell Biology
  • Urology

Background:

  • Prostate cancer (CaP) diagnosis and characterization rely on accurate cellular markers.
  • Understanding the role of specific proteins in prostate basal cell biology is crucial for CaP research.

Purpose of the Study:

  • To investigate the expression pattern of p63 in various prostate tissue types and cell cultures.
  • To determine the utility of p63 as a specific marker for prostate basal cells and in vitro CaP cell typing.

Main Methods:

  • Tissue microarray analysis of benign prostate glands, prostatic intraepithelial neoplasia, and prostatic carcinoma.
  • Immunohistochemical staining using an anti-p63 antibody.
  • Evaluation of p63 expression in different prostate cell culture conditions (immortalized, early passage, senescent, and metastatic).

Related Experiment Videos

Main Results:

  • p63 expression was exclusively localized to the nuclei of basal cells in prostate tissues.
  • Detectable p63 was observed in immortalized and early passage prostate cell cultures.
  • p63 was notably absent in senescent cell cultures and cell lines derived from metastatic prostate tumors.

Conclusions:

  • p63 serves as a specific and reliable marker for prostate basal cells.
  • The expression profile of p63 is valuable for in vitro typing of prostate cancer cell cultures.
  • p63 plays a significant role in the fundamental biology of prostate basal cells.